CastleKnight Management’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.22M Sell
1,076,967
-90,980
-8% -$816K 0.15% 90
2025
Q4
$10.3M Sell
1,167,947
-570,969
-33% -$6.6M 0.23% 56
2025
Q3
$23M Buy
1,738,916
+510,747
+42% +$6.39M 0.45% 31
2025
Q2
$16.8M Buy
1,228,169
+235,693
+24% +$3.17M 0.47% 34
2025
Q1
$13.6M Sell
992,476
-40,439
-4% -$590K 0.54% 26
2024
Q4
$17.6M Buy
1,032,915
+535,466
+108% +$9.28M 0.52% 17
2024
Q3
$9.14M Buy
+497,449
New +$8.79M 0.38% 28

Other funds holding ARDT

CastleKnight Management's ARDT Position: Q1 2026 in Review

CastleKnight Management reduced its Ardent Health (ARDT) stake by 7.8% in Q1 2026, selling an estimated $816K and leaving 1,076,967 shares worth $9.22M. The position accounts for 0.15% of the portfolio, ranked #90.

CastleKnight Management first reported a position in ARDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $23M in Q3 2025. 136 funds tracked by Wall St. Rank hold ARDT as of Q1 2026.

  • CastleKnight Management held 1,076,967 shares of Ardent Health worth $9.22M as of Q1 2026.
  • CastleKnight Management sold 90,980 Ardent Health shares in Q1 2026, an estimated $816K.
  • Ardent Health made up 0.15% of CastleKnight Management's portfolio in Q1 2026, its #90 holding.
  • CastleKnight Management first reported a position in Ardent Health in Q3 2024 and has held it in 7 quarters since.
  • CastleKnight Management's Ardent Health position peaked at $23M in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Ardent Health as of Q1 2026.

Based on CastleKnight Management's 13F filing for Q1 2026, filed 15 May 2026.